Vanda Pharmaceuticals
VNDA
#7202
Rank
ยฃ0.36 B
Marketcap
ยฃ6.14
Share price
4.59%
Change (1 day)
65.20%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ30.45 Million a decrease over its 2023 earnings that were of -ยฃ10.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million199.79%
2024 -ยฃ30.45 Million191.43%
2023 -ยฃ10.45 Million-320.45%
2022 ยฃ4.73 M-84.99%
2021 ยฃ31.56 M54.8%
2020 ยฃ20.39 M19.42%
2019 ยฃ17.07 M4.93%
2018 ยฃ16.27 M-228.6%
2017 -ยฃ12.66 Million-8.98%
2016 -ยฃ13.91 Million-53.79%
2015 -ยฃ30.09 Million-30.18%
2014 -ยฃ43.09 Million173.08%
2013 -ยฃ15.78 Million-25.33%
2012 -ยฃ21.14 Million163.61%
2011 -ยฃ8.02 Million-221.15%
2010 ยฃ6.61 M-124.53%
2009 -ยฃ26.98 Million-29.44%
2008 -ยฃ38.23 Million-36.2%
2007 -ยฃ59.93 Million21.81%
2006 -ยฃ49.2 Million170.55%
2005 -ยฃ18.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.25 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.24 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ8.87 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.84 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.28 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.01 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.1 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA